» Articles » PMID: 31388568

Quality Assuring "Plan of the Day" Selection in a Multicentre Adaptive Bladder Trial: Implementation of a Pre-accrual IGRT Guidance and Assessment Module

Overview
Specialty Oncology
Date 2019 Aug 8
PMID 31388568
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Purpose: Hypofractionated bladder RT with or without image guided adaptive planning (HYBRID) is a multicentre clinical trial investigating "Plan of the Day" (PoD) adaptive radiotherapy for bladder cancer. To ensure correct PoD selection a pre-accrual guidance and assessment module was developed as part of an image guided radiotherapy quality assurance (IGRT QA) credentialing programme. This study aimed to evaluate its feasibility and effectiveness across multiple recruiting centres.

Materials And Methods: Individuals from participating centres remotely accessed an image database in order to complete the PoD module. An assessment score of ≥83% was required in order to receive QA approval. A questionnaire was used to gather user feedback on the module. PoD decisions for the first patient at each recruiting centre were retrospectively reviewed for protocol adherence.

Results: 71 radiation therapists (RTTs) from 10 centres completed the PoD module. The median assessment score was 92% (Range: 58-100%) with 79% of RTTs passing the assessment on first attempt. All questionnaire respondents reported that the PoD module prepared them for plan selection. In 51/60 of on-trial treatments reviewed, the PoD selected by the centre agreed with QA reviewers.

Conclusions: The PoD QA module was successfully implemented in a multicentre trial and enabled pre-accrual assessment of protocol understanding. This increased operator confidence and resulted in appropriate PoD selection on-trial.

Citing Articles

Pelvic target volume inter-fractional motion during radiotherapy for cervical cancer with daily iterative cone beam computed tomography.

Zeng Z, Zhu J, Wang Z, Wang G, Yan J, Zhang F Radiat Oncol. 2024; 19(1):48.

PMID: 38622628 PMC: 11017626. DOI: 10.1186/s13014-024-02438-1.


Recognising the challenges of implementing multi-centre adaptive plan of the day radiotherapy.

Webster A, McNair H, Hansen V, Lewis R, Patel E, Miles E Tech Innov Patient Support Radiat Oncol. 2022; 21:31-35.

PMID: 35198744 PMC: 8841376. DOI: 10.1016/j.tipsro.2022.01.002.


Pathway for radiation therapists online advanced adapter training and credentialing.

Shepherd M, Graham S, Ward A, Zwart L, Cai B, Shelley C Tech Innov Patient Support Radiat Oncol. 2021; 20:54-60.

PMID: 34917781 PMC: 8665404. DOI: 10.1016/j.tipsro.2021.11.001.


Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance.

Hafeez S, Webster A, Hansen V, McNair H, Warren-Oseni K, Patel E BMJ Open. 2021; 10(12):e041005.

PMID: 33384390 PMC: 7780718. DOI: 10.1136/bmjopen-2020-041005.


Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer.

Huddart R, Hafeez S, Lewis R, McNair H, Syndikus I, Henry A Int J Radiat Oncol Biol Phys. 2020; 110(2):412-424.

PMID: 33316362 PMC: 8114997. DOI: 10.1016/j.ijrobp.2020.11.068.


References
1.
Tsang Y, Baker A, Patel E, Miles E . A new era for clinical trial quality assurance: A credentialing programme for RTT led adaptive radiotherapy. Tech Innov Patient Support Radiat Oncol. 2020; 5:1-2. PMC: 7033801. DOI: 10.1016/j.tipsro.2017.12.001. View

2.
Foroudi F, Pham D, Bressel M, Tongs D, Rolfo A, Styles C . The utility of e-Learning to support training for a multicentre bladder online adaptive radiotherapy trial (TROG 10.01-BOLART). Radiother Oncol. 2012; 109(1):165-9. DOI: 10.1016/j.radonc.2012.10.019. View

3.
Lalondrelle S, Huddart R, Warren-Oseni K, Hansen V, McNair H, Thomas K . Adaptive-predictive organ localization using cone-beam computed tomography for improved accuracy in external beam radiotherapy for bladder cancer. Int J Radiat Oncol Biol Phys. 2010; 79(3):705-12. DOI: 10.1016/j.ijrobp.2009.12.003. View

4.
Kron T, Pham D, Roxby P, Rolfo A, Foroudi F . Credentialing of radiotherapy centres for a clinical trial of adaptive radiotherapy for bladder cancer (TROG 10.01). Radiother Oncol. 2012; 103(3):293-8. DOI: 10.1016/j.radonc.2012.03.003. View

5.
McDonald F, Lalondrelle S, Taylor H, Warren-Oseni K, Khoo V, McNair H . Clinical implementation of adaptive hypofractionated bladder radiotherapy for improvement in normal tissue irradiation. Clin Oncol (R Coll Radiol). 2013; 25(9):549-56. DOI: 10.1016/j.clon.2013.06.001. View